Molecules/EFALIZUMAB

EFALIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2003

Mechanism of action: Integrin alpha-L/beta-2 (LFA-1) inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ANTI-CD11AEFALIZUMABHU-1124HU1124RAPTIVA

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to EFALIZUMAB

Loading drug network...